Boundless Bio, Inc.
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.16% | 11.46% | 0.53% | 4.20% | 0.37% |
| Total Depreciation and Amortization | -0.97% | -2.21% | 0.00% | 7.09% | 12.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.40% | -16.01% | -1.09% | 7.17% | 25.83% |
| Change in Net Operating Assets | -55.01% | 7.95% | 284.57% | 17.67% | -169.59% |
| Cash from Operations | 0.86% | 13.81% | 18.59% | 6.64% | -17.31% |
| Capital Expenditure | -2,726.67% | 68.75% | 18.64% | 87.34% | 3.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 27.66% | -7.47% | 263.58% | 36.26% | -89.88% |
| Cash from Investing | 23.79% | -7.21% | 269.02% | 67.86% | -91.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -- | -100.00% | -- | -- | 969.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 920.49% | 167.38% | 96.34% | 15.83% | -253.96% |